Etiology of Sarcoidosis

Clinics in Chest Medicine

Volumn 29, Issue 3, 2008, Pages 365-377

  Chen, Edward S ^a   Moller, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VIRULENCE; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; LUNG DISEASE; MYCOBACTERIUM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPIONIBACTERIACEAE; REVIEW; SARCOIDOSIS; VIRUS VIRULENCE;

ANIMALS; ENVIRONMENTAL EXPOSURE; HUMANS; IMMUNITY, CELLULAR; INFECTION; RISK FACTORS; SARCOIDOSIS;

EID: 44649180530     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.03.011     Document Type: Review

References (91)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 2 (1999) 736-755
2. Saunders B.M., and Cooper A.M. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol Cell Biol 78 4 (2000) 334-341
3. Baughman R.P., Teirstein A.S., Judson M.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164 10 Pt 1 (2001) 1885-1889
4. Baird M.M., Bogoch A., and Fenwick J.B. Liver biopsy in sarcoidosis. Can Med Assoc J 62 6 (1950) 562-565
5. Judson M.A., Baughman R.P., Thompson B.W., et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 20 3 (2003) 204-211
6. Hunninghake G.W., and Crystal R.G. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 305 8 (1981) 429-434
7. Morris D.G., Jasmer R.M., Huang L., et al. Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence. Chest 124 3 (2003) 929-935
8. Moller D.R., Forman J.D., Liu M.C., et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 156 12 (1996) 4952-4960
9. Nakajima M., Kubota Y., Miyashita N., et al. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C. Intern Med 35 5 (1996) 376-379
10. Logan T.F., and Bensadoun E.S. Increased disease activity in a patient with sarcoidosis after high dose interleukin 2 treatment for metastatic renal cancer. Thorax 60 7 (2005) 610-611
11. Foulon G., Wislez M., Naccache J.M., et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 38 3 (2004) 418-425
12. Chiu B.C., Freeman C.M., Stolberg V.R., et al. Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation. Am J Respir Cell Mol Biol 29 1 (2003) 106-116
13. Grunewald J., and Eklund A. Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 4 5 (2007) 461-464
14. Grunewald J., Wahlstrom J., Berlin M., et al. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax 57 4 (2002) 348-352
15. Silver R.F., Crystal R.G., and Moller D.R. Limited heterogeneity of biased T-cell receptor V beta gene usage in lung but not blood T cells in active pulmonary sarcoidosis. Immunology 88 4 (1996) 516-523
16. Sawabe T., Shiokawa S., Sugisaki K., et al. Accumulation of common clonal T cells in multiple lesions of sarcoidosis. Mol Med 6 9 (2000) 793-802
17. Veltkamp M., Wijnen P.A., van Moorsel C.H., et al. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol 149 3 (2007) 453-462
18. Luisetti M., Beretta A., and Casali L. Genetic aspects in sarcoidosis. Eur Respir J 16 4 (2000) 768-780
19. Schurmann M., Reichel P., Muller-Myhsok B., et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 164 5 (2001) 840-846
20. Iannuzzi M.C., Iyengar S.K., Gray-McGuire C., et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 6 6 (2005) 509-518
21. Valentonyte R., Hampe J., Huse K., et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37 4 (2005) 357-364
22. Rybicki B.A., Walewski J.L., Maliarik M.J., et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 77 3 (2005) 491-499
23. Iannuzzi M.C., Maliarik M.J., Poisson L.M., et al. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 167 9 (2003) 1225-1231
24. Berenson L.S., Ota N., and Murphy K.M. Issues in T-helper 1 development-resolved and unresolved. Immunol Rev 202 (2004) 157-174
25. Dabbagh K., and Lewis D.B. Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opin Infect Dis 16 3 (2003) 199-204
26. Miyara M., Amoura Z., Parizot C., et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203 2 (2006) 359-370
27. Hunninghake GW. Sarcoidosis; Past, Present and Future. ATS 2006 International Conference, Amberson Lecture. San Diego, May 21, 2006.
28. Siltzbach L.E. The Kveim test in sarcoidosis. A study of 750 patients. JAMA 178 (1961) 476-482
29. Klein J.T., Horn T.D., Forman J.D., et al. Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 154 3 (1995) 1450-1460
30. Holter J.F., Park H.K., Sjoerdsma K.W., et al. Nonviable autologous bronchoalveolar lavage cell preparations induce intradermal epithelioid cell granulomas in sarcoidosis patients. Am Rev Respir Dis 145 4 Pt 1 (1992) 864-871
31. Song Z., Marzilli L., Greenlee B.M., et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 201 5 (2005) 755-767
32. Dunner E., and Williams Jr. J.H. Epidemiology of sarcoidosis in the United States. Am Rev Respir Dis 84 5Pt 2 (1961) 163-168
33. Kajdasz D.K., Lackland D.T., Mohr L.C., et al. A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol 11 2 (2001) 111-117
34. Sarcoidosis among U.S. Navy enlisted men, 1965-1993. MMWR Morb Mortal Wkly Rep 46 23 (1997) 539-543
35. Prezant D.J., Dhala A., Goldstein A., et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 116 5 (1999) 1183-1193
36. Newman L.S., Rose C.S., Bresnitz E.A., et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170 12 (2004) 1324-1330
37. Barnard J., Rose C., Newman L., et al. Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 47 3 (2005) 226-234
38. Kreider M.E., Christie J.D., Thompson B., et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 128 1 (2005) 207-215
39. Newman L.S., Mroz M.M., Balkissoon R., et al. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 171 1 (2005) 54-60
40. Fontenot A.P., Canavera S.J., Gharavi L., et al. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest 110 10 (2002) 1473-1482
41. Pott G.B., Palmer B.E., Sullivan A.K., et al. Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease. J Allergy Clin Immunol 115 5 (2005) 1036-1042
42. Fontenot A.P., Palmer B.E., Sullivan A.K., et al. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response. J Clin Invest 115 10 (2005) 2886-2893
43. Sackett H.M., Maier L.A., Silveira L.J., et al. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med 46 9 (2004) 953-961
44. Kreiss K., Mroz M.M., Newman L.S., et al. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3. Am J Ind Med 30 1 (1996) 16-25
45. Saltini C., and Richeldi L. A genetic marker for chronic beryllium disease. Med Lav 86 3 (1995) 226-228
46. Muller-Quernheim J., Gaede K.I., Fireman E., et al. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 27 6 (2006) 1190-1195
47. Kelleher P., Pacheco K., and Newman L.S. Inorganic dust pneumonias: the metal-related parenchymal disorders. Environ Health Perspect 108 Suppl 4 (2000) 685-696
48. Drent M., Bomans P.H., Van Suylen R.J., et al. Association of man-made mineral fibre exposure and sarcoidlike granulomas. Respir Med 94 8 (2000) 815-820
49. Churg A., Muller N.L., Flint J., et al. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 30 2 (2006) 201-208
50. Respiratory illness in workers exposed to metalworking fluid contaminated with nontuberculous mycobacteria-Ohio, 2001. MMWR Morb Mortal Wkly Rep 51 16 (2002) 349-352
51. Izbicki G., Chavko R., Banauch G.I., et al. World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 131 5 (2007) 1414-1423
52. Rossman M.D., and Kreider M.E. Is chronic beryllium disease sarcoidosis of known etiology?. Sarcoidosis Vasc Diffuse Lung Dis 20 2 (2003) 104-109
53. Shvedova A.A., Kisin E.R., Mercer R., et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289 5 (2005) L698-L708
54. El-Zammar O.A., and Katzenstein A.L. Pathological diagnosis of granulomatous lung disease: a review. Histopathology 50 3 (2007) 289-310
55. Alavi H.A., and Moscovic E.A. Immunolocalization of cell-wall-deficient forms of Mycobacterium tuberculosis complex in sarcoidosis and in sinus histiocytosis of lymph nodes draining carcinoma. Histol Histopathol 11 3 (1996) 683-694
56. Hanngren A., Odham G., Eklund A., et al. Tuberculostearic acid in lymph nodes from patients with sarcoidosis. Sarcoidosis 4 2 (1987) 101-104
57. Sutherland I., Mitchell D.N., and Hart P.D. Incidence of Intrathoracic Sarcoidosis among Young Adults Participating in a Trial of Tuberculosis Vaccines. Br Med J 2 5460 (1965) 497-503
58. Grange J.M., Gibson J., Nassau E., et al. Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis and Crohn's disease. Tubercle 61 3 (1980) 145-152
59. Milman N., and Andersen A.B. Detection of antibodies in serum against M. tuberculosis using western blot technique. Comparison between sarcoidosis patients and healthy subjects. Sarcoidosis 10 1 (1993) 29-31
60. Hance A.J. The role of mycobacteria in the pathogenesis of sarcoidosis. Semin Respir Infect 13 3 (1998) 197-205
61. Gupta D., Agarwal R., Aggarwal A.N., et al. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 30 3 (2007) 508-516
62. Drake W.P., Pei Z., Pride D.T., et al. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 8 11 (2002) 1334-1341
63. Gazouli M., Ikonomopoulos J., Trigidou R., et al. Assessment of mycobacterial, propionibacterial, and human herpes virus 8 DNA in tissues of Greek patients with sarcoidosis. J Clin Microbiol 40 8 (2002) 3060-3063
64. Fite E., Fernandez-Figueras M.T., Prats R., et al. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 73 1 (2006) 20-26
65. Marcoval J., Benitez M.A., Alcaide F., et al. Absence of ribosomal RNA of Mycobacterium tuberculosis complex in sarcoidosis. Arch Dermatol 141 1 (2005) 57-59
66. Chase M.W., and Siltzbach L.E. Concentration of the active principle resopnsible for the Kveim reaction. In: Turiaf J., and Chabot J. (Eds). La sarcoïdose (1967), Masson et Cie, Paris
67. Drake W.P., Dhason M.S., Nadaf M., et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 75 1 (2007) 527-530
68. Carlisle J., Evans W., Hajizadeh R., et al. Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol 150 3 (2007) 460-468
69. Hajizadeh R., Sato H., Carlisle J., et al. Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis. J Clin Immunol 27 4 (2007) 445-454
70. Homma J.Y., Abe C., Chosa H., et al. Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med 48 3 (1978) 251-255
71. Eishi Y., Suga M., Ishige I., et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40 1 (2002) 198-204
72. Ishige I., Eishi Y., Takemura T., et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 1 (2005) 33-42
73. Ebe Y., Ikushima S., Yamaguchi T., et al. Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 17 3 (2000) 256-265
74. Bachelez H., Senet P., Cadranel J., et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137 1 (2001) 69-73
75. Labro M.T. Antibiotics as anti-inflammatory agents. Curr Opin Investig Drugs 3 1 (2002) 61-68
76. Minami J., Eishi Y., Ishige Y., et al. Pulmonary granulomas caused experimentally in mice by a recombinant trigger-factor protein of Propionibacterium acnes. J Med Dent Sci 50 4 (2003) 265-274
77. McCaskill J.G., Chason K.D., Hua X., et al. Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice. Am J Respir Cell Mol Biol 35 3 (2006) 347-356
78. Nikoskelainen J., Hannuksela M., and Palva T. Antibodies to Epstein-Barr virus and some other herpes viruses in patients with sarcoidosis, pulmonary tuberculosis and erythema nodosum. Scand J Infect Dis 6 3 (1974) 209-216
79. James D.G., and Lipman M.C. Whipple's disease: a granulomatous masquerader. Clin Chest Med 23 2 (2002) 513-519 xi-xii
80. Schilstra A., Rottoli P., Jacobs J.A., et al. Case studies to explore the pitfalls in the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23 2 (2006) 135-140
81. Brown S.T., Brett I., Almenoff P.L., et al. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest 123 2 (2003) 413-417
82. Sadikot R.T., Dore P., and Arnold A.G. Sarcoidosis and opportunistic infections. South Med J 94 1 (2001) 75-77
83. Sapadin A.N., and Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54 2 (2006) 258-265
84. Heyll A., Meckenstock G., Aul C., et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 14 1 (1994) 161-164
85. Sundar K.M., Carveth H.J., Gosselin M.V., et al. Granulomatous pneumonitis following bone marrow transplantation. Bone Marrow Transplant 28 6 (2001) 627-630
86. Martinez F.J., Orens J.B., Deeb M., et al. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest 106 5 (1994) 1597-1599
87. Padilla M.L., Schilero G.J., and Teirstein A.S. Donor-acquired sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 19 1 (2002) 18-24
88. Milman N., Andersen C.B., Burton C.M., et al. Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells. Eur Respir J 26 3 (2005) 549-552
89. Klemen H., Husain A.N., Cagle P.T., et al. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung-a PCR-based study on four cases. Virchows Arch 436 4 (2000) 365-369
90. Cosma C.L., Humbert O., and Ramakrishnan L. Superinfecting mycobacteria home to established tuberculous granulomas. Nat Immunol 5 8 (2004) 828-835
91. Rachman H., Strong M., Schaible U., et al. Mycobacterium tuberculosis gene expression profiling within the context of protein networks. Microbes Infect 8 3 (2006) 747-757